Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.41 |
| ▸ | FABP4 | P15090 | 5/20 | 0.38 |
| ▸ | FABP3 | P05413 | 3/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.38 |
| ▸ | EIF4E | P06730 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5419835 | 0.87 | FABP4 (0.47) | ALDH1A1CNR1FABP4FABP3FABP5 | |
| SCHEMBL5437372 | 0.81 | GAA (0.50) | ALDH1A1CNR1GAAFABP4FABP3 | |
| SCHEMBL30349584 | 0.74 | ALDH1A1 (0.56) | ALDH1A1ALOX15GAARAB9ASMN1; SMN2 | |
| SCHEMBL284068 | 0.74 | ALDH1A1 (0.56) | ALDH1A1ALOX15GAARAB9ASMN1; SMN2 | |
| SCHEMBL28304145 | 0.74 | ALDH1A1 (0.45) | ALDH1A1ALOX15CNR1FABP4FABP3 | |
| SCHEMBL5423580 | 0.72 | GRIA1 (0.44) | CNR1GRIA1CACNG8 | |
| SCHEMBL343535 | 0.70 | CES2 (0.68) | ALDH1A1ALOX15RAB9A | |
| SCHEMBL27770146 | 0.69 | FABP3 (0.54) | ALDH1A1ALOX15FABP4FABP3FABP5 | |
| SCHEMBL27731122 | 0.69 | CASP1 (0.57) | ALDH1A1 | |
| SCHEMBL29454770 | 0.69 | ALDH1A1 (0.54) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135497-A1 | Biphenyl derivative or its salt, and pesticide containing it as an active ingredient | ISHIHARA SANGYO KAISHA LTD. (JP) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135497-A1 | Biphenyl derivative or its salt, and pesticide containing it as an active ingredient | DDT, HCN1, HCN2 | ALDH1A1 3141/4885ALOX15 1355/4885CNR1 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.